MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 31
21-11-2013
HBA 16p Thalassemisas, Alpha
Vs. 32 06-06-2014 HBA 16p Thalassemisas, Alpha
Vs. 33 27-11-2014 HBA 16p Thalassemisas, Alpha
Vs. 34 03-12-2015 HBA 16p Thalassemisas, Alpha
Vs. C1-01 16-08-2016 HBA 16p Thalassemisas, Alpha
Vs. C1-02 03-04-2017 HBA 16p Thalassemisas, Alpha
Vs. 07
17-06-2008
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 10
02-10-2011
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 12
01-03-2013
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 14
20-11-2015
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 15
05-01-2017
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 07
17-06-2008
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 10
02-10-2011
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 12
01-03-2013
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 14
20-11-2015
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 15
05-01-2017
NIPBL 5q13.1 Cornelia de Lange syndrome (CDLS)
Vs. 04
17-06-2007
MFN2 1p36.2, MPZ 1q22

Charot-Marie-Tooth disease (CMT2A/1B)

Vs. 05
31-01-2010
MFN2 1p36.2, MPZ 1q22

Charot-Marie-Tooth disease (CMT2A/1B)

Vs. 07
20-12-2012
MFN2 1p36.2, MPZ 1q22

Charot-Marie-Tooth disease (CMT2A/1B)

Vs. 08
29-11-2013
MFN2 1p36.2, MPZ 1q22

Charot-Marie-Tooth disease (CMT2A/1B)

Vs. 09
25-04-2017
MFN2 1p36.2, MPZ 1q22

Charot-Marie-Tooth disease (CMT2A/1B)

Vs. 05
17-12-2011
Chr. 5, 7, 8, 11, 12, 17, 20, 21

Myelodysplastic syndrome (MDS)

Vs. 05
17-12-2011
Chr. 5, 7, 8, 11, 12, 17, 20, 21

Myelodysplastic syndrome (MDS)

Vs. 07
22-01-2010
1p36 1p36 deletion syndrome
Vs. 10
02-10-2011
1p36 1p36 deletion syndrome
Vs. 13
01-03-2013
1p36 1p36 deletion syndrome
Vs. 14
31-05-2017
1p36 1p36 deletion syndrome
Vs. 05
07-03-2009
TGFBR1 9q22, TGFBR2 3p22 Aortic aneurysm syndrome
Vs. 07
09-10-2011
TGFBR1 9q22, TGFBR2 3p22 Aortic aneurysm syndrome
Vs. 08
06-08-2012
TGFBR1 9q22, TGFBR2 3p22 Aortic aneurysm syndrome
Vs. 09
20-12-2012
TGFBR1 9q22, TGFBR2 3p22 Aortic aneurysm syndrome
Vs. 10
22-04-2015
TGFBR1 9q22, TGFBR2 3p22 Aortic aneurysm syndrome
Vs. 11
01-02-2018
TGFBR1 9q22, TGFBR2 3p22 Aortic aneurysm syndrome
Vs. 11
22-07-2015
ABCA4 (ABCR) 1p22.1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration
Vs. 12
07-12-2015
ABCA4 (ABCR) 1p22.1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration
Vs. 13
09-06-2016
ABCA4 (ABCR) 1p22.1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration
Vs. 11
22-07-2015
ABCA4 (ABCR) 1p22.1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration
Vs. 12
07-12-2015
ABCA4 (ABCR) 1p22.1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration
P152-B2 Vs. 13 09-06-2016 ABCA4 (ABCR) 1p22.1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration
Vs. 06

28-01-2009

EYA1 8q13.3. Branchio-oto-renal dysplasia syndrome (BOR)
Vs. 10

09-10-2011

EYA1 8q13.3. Branchio-oto-renal dysplasia syndrome (BOR)
Vs. 12
26-09-2014 EYA1 8q13.3. Branchio-oto-renal dysplasia syndrome (BOR)
Vs. 13
22-01-2016 EYA1 8q13.3. Branchio-oto-renal dysplasia syndrome (BOR)
Vs. 05
17-06-2008
GPC3, GPC4, Xq26 Simpson-Golabi-Behmel syndrome (SGBS)
Vs. 07
06-12-2010
GPC3, GPC4, Xq26 Simpson-Golabi-Behmel syndrome (SGBS)
Vs. 09
03-12-2012
GPC3, GPC4, Xq26 Simpson-Golabi-Behmel syndrome (SGBS)
Vs. 10
08-12-2014
GPC3, GPC4, Xq26 Simpson-Golabi-Behmel syndrome (SGBS)
Vs. 12
13-07-2017
GPC3, GPC4, Xq26 Simpson-Golabi-Behmel syndrome (SGBS)
Vs. 09
09-10-2011
COL3A1 2q31, TNXB 6p21.3. The Ehlers-Danlos syndrome type III (EDS III)
Vs. 10
28-03-2012
COL3A1 2q31, TNXB 6p21.3. The Ehlers-Danlos syndrome type III (EDS III)
Vs. 11
20-12-2012
COL3A1 2q31, TNXB 6p21.3. The Ehlers-Danlos syndrome type III (EDS III)
Vs. 12
20-04-2015
COL3A1 2q31, TNXB 6p21.3. The Ehlers-Danlos syndrome type III (EDS III)
Vs. 13
04-11-2016
COL3A1 2q31, TNXB 6p21.3. The Ehlers-Danlos syndrome type III (EDS III)
Vs. 14
28-08-2017
COL3A1 2q31, TNXB 6p21.3. The Ehlers-Danlos syndrome type III (EDS III)
Vs. 06
22-02-2010
GALT 9p13 Classic galactosemia
P156-B1 Vs. 07 09-10-2011 GALT 9p13 Classic galactosemia
P156-B2 Vs. 09 28-03-2014 GALT 9p13 Classic galactosemia
Vs. 05
09-06-2008
BCL2L1, SRC, MYBL2, PTPN1, ZNF217, BCAS1, GNAS 20q
Vs. 09
01-03-2013
BCL2L1, SRC, MYBL2, PTPN1, ZNF217, BCAS1, GNAS 20q
Vs. 13
09-04-2011
BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
Vs. 14
16-10-2011
BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
P158-C1 Vs. 15 09-12-2012 BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
P158-C2 Vs. 16 05-06-2014 BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
P158-C2 Vs. 18 24-08-2015 BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
P158-C2 Vs. 19 29-02-2016 BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
P158-C2 Vs. 20 11-08-2017 BMPR1A 10q22, SMAD4 18q21, PTEN Juvenile polyposis syndrome (JPS)
Vs. 07
24-01-2011
GLA Xq22 Fabry Disease
Vs. 08
08-11-2011
GLA Xq22 Fabry Disease
Vs. 09
09-12-2012
GLA Xq22 Fabry Disease
Vs. 10
21-01-2015
GLA Xq22 Fabry Disease
Vs. 11
17-08-2016
GLA Xq22 Fabry Disease
Vs. 12
10-01-2017
GLA Xq22 Fabry Disease
Vs. 13
03-03-2017
GLA Xq22 Fabry Disease